It would be fascinating to watch a brilliant biochemist engineer a highly selective kinase activator (or phosphatase inhibitor) that targets phosphorylation at the N-terminal domain serines of the androgen receptor-particularly Ser81 and/or Ser213.
Theoretically, boosting phosphorylation at these sites could amplify AR transcriptional activity and enhance skeletal muscle hypertrophy, especially via cross-talk with growth factor pathways like IGF-1/Akt for Ser213. In an ideal world, this approach would deliver muscle-specific gains with zero off-target effects.
I've thought about pitching this idea to a few chemists I know – including PA.
Something in the future possibly but right now there's not anything that has come out that surpasses steroids for muscle growth nothing. Peptides have their place each peptide has a specific function but not for muscle growth. Anabolic Steroids are the Best! The Basics Always Work! That goes for everything.Most compounds we use today are decades old. Aside from delivery methods and minor tweaks, are we actually seeing innovation or just repackaging the same drugs?
Is there really anything groundbreaking left?
Yeah dude, I remember Turkesterone being all the rage something like 2 decades ago, then nothing, then in about '21/'22 it was back in full force for some reason. Still doing nothing, at least not doing enough to justify it's cost. I feel like Colostrum was a similar thing.I think the industry is no different than the supplement industry. “All that is old becomes new again.”
Most industry’s just cycle through things as people make them fads. Collagen, creatine, magnesium. None are new by any stretch, but they sure seem like it right now due to how they’re marketed.
The PED space is much in the same- high test, high mast, orals, no orals. It’s whatever the influential people talk about and make stick.
I think people will continue to play with myostatin through bioregulators, which I believe are the next trend as a whole- bioregulators.
Agreed on the peptides- BPC and TB500 have been great additions, but they are not new by any means. The rest of the world just thinks they are because influencers started white listing them. Same with GLP’s, influencers made it “ok” or the new norm for the masses to take them, and from UGL sources.Yeah dude, I remember Turkesterone being all the rage something like 2 decades ago, then nothing, then in about '21/'22 it was back in full force for some reason. Still doing nothing, at least not doing enough to justify it's cost. I feel like Colostrum was a similar thing.
That said, I do think things like BPC/TB, possibly other peps, and obviously GLP-1's are here to stay, these are effective and relatively safe, and beneficial to many different demographics.
SARMs are another thing that I think will lose steam if they even still have steam right now.
Yeah Patrick found an old book with about 4-500 diff steroids that never made it into the "world of medicine" and so they didnt have profiles of it, structure etc so he found the a couple and tried em out on athletes.The industry seems to be focused on peptides. We'll see which of these novel compounds have staying power
I remember reading about Vic Conte. How did a musician synthesize a new, undetectable steroid. I'm sure many are now aware, but he didn't. He found tetrahydrogestrinone in old Russian literature and Patrick Arnold synthesized it.
With the help of AI tools will someone be able to develop a new androgen structure? Or locate another compound in forgotten research that was never pursued further?
I expect pharmaceutical companies are researching ways to mitigate the potential muscle loss associated with GLP use.
I remain highly skeptical of any claims of successful myostatin inhibition. I can't intuit how such a compound wouldn't also affect cardiac muscle tissue.
It would be fascinating to watch a brilliant biochemist engineer a highly selective kinase activator (or phosphatase inhibitor) that targets phosphorylation at the N-terminal domain serines of the androgen receptor-particularly Ser81 and/or Ser213.
Theoretically, boosting phosphorylation at these sites could amplify AR transcriptional activity and enhance skeletal muscle hypertrophy, especially via cross-talk with growth factor pathways like IGF-1/Akt for Ser213. In an ideal world, this approach would deliver muscle-specific gains with zero off-target effects.
I've thought about pitching this idea to a few chemists I know – including PA.
Dude have you seen drone warfare ? no goverment gives a fuck about you being big..This is going to come off as I'm a tinfoil hat wearer when I'm not but it doesn't make any sense for government to let their general population get jacked as fuck with drugs. I don't think in our lifetime, that we're going to see anything new that is proven to increase contractile tissue at a rapid rate without killing you within 5 years of use.
This is going to come off as I'm a tinfoil hat wearer when I'm not but it doesn't make any sense for government to let their general population get jacked as fuck with drugs. I don't think in our lifetime, that we're going to see anything new that is proven to increase contractile tissue at a rapid rate without killing you within 5 years of use.
Have you tried YK11? There are few reviews about this product, and they're very mixed from what I remember.We already have things like YK11 that are much stronger for myostatin IMO.











































































